Advanced

A novel model for Ki67 assessment in breast cancer.

Romero, Quinci LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Grabau, Dorthe LU and Borgquist, Signe LU (2014) In Diagnostic Pathology 9(1).
Abstract
Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diagnostic Pathology
volume
9
issue
1
publisher
BioMed Central
external identifiers
  • pmid:24934660
  • wos:000338264000003
  • scopus:84903142118
ISSN
1746-1596
DOI
10.1186/1746-1596-9-118
language
English
LU publication?
yes
id
54ac8b7c-69bf-434e-9ec1-063165e6c628 (old id 4528395)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24934660?dopt=Abstract
date added to LUP
2014-07-06 11:31:14
date last changed
2017-08-27 04:37:27
@article{54ac8b7c-69bf-434e-9ec1-063165e6c628,
  abstract     = {Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.},
  articleno    = {118},
  author       = {Romero, Quinci and Bendahl, Pär-Ola and Fernö, Mårten and Grabau, Dorthe and Borgquist, Signe},
  issn         = {1746-1596},
  language     = {eng},
  number       = {1},
  publisher    = {BioMed Central},
  series       = {Diagnostic Pathology},
  title        = {A novel model for Ki67 assessment in breast cancer.},
  url          = {http://dx.doi.org/10.1186/1746-1596-9-118},
  volume       = {9},
  year         = {2014},
}